Fuxiang Shares: Announcement on the progress of the company's provision of guarantees for wholly-owned subsidiaries
Securities code: 300497 Securities abbreviation: Fuxiang Shares Announcement number: 2026-074
Jiangxi Fuxiang Pharmaceutical Co., Ltd.
Announcement on the progress of the company's provision of guarantees for wholly-owned subsidiaries
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
1. Overview of guarantee situation
Jiangxi Fuxiang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the eighth meeting of the fifth board of directors and the 2025 annual shareholders' meeting on April 24, 2026 and May 21, 2026 respectively, and reviewed and approved the "Proposal on Applying for a Comprehensive Credit Line from the Bank and Providing Guarantees for Subsidiaries". It is agreed that the company will provide guarantees for some subsidiaries to apply for comprehensive credit lines from banks in 2026, with the guarantee amount not exceeding 1.515 billion yuan, of which the guarantee amount provided for Jingdezhen Fuxiang Life Technology Co., Ltd. (hereinafter referred to as "Fuxiang Technology") will not exceed 730 million yuan. The guarantee line will be valid for one year from the date of review and approval at the 2025 Annual General Meeting of Shareholders. The guarantee line can be recycled during the validity period. The guarantee item is a bank's comprehensive credit, which can be used to handle short-term working capital loans, project loans, bank acceptance bills, discounts, letters of guarantee, letters of credit, export factoring and other businesses. For details, please refer to the "Announcement on Applying for a Comprehensive Credit Line from the Bank and Providing Guarantees for Subsidiaries" disclosed by the company on cninfo.com (announcement number: 2026-037).
2. Guarantee progress
Recently, the company signed a "Guarantee Contract" (C260730GR3624014) with Jingdezhen Branch of Bank of Communications Co., Ltd. (hereinafter referred to as "Bank of Communications Jingdezhen Branch") to provide Fuxiang Technology with a guarantee on July 3, 2026. All main contracts signed with Bank of Communications Jingdezhen Branch from January 0 to January 30, 2028 provide the maximum amount of guarantee, and the maximum amount of claims guaranteed by the guarantor is RMB 150,000,000 (¥150,000,000).
According to the provisions of the "Shenzhen Stock Exchange GEM Stock Listing Rules", "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" and other relevant documents, the above guarantee limit is already within the limit approved by the company's board of directors and shareholders' meeting, and does not need to be submitted to the company's board of directors or shareholders' meeting for review.
3. Basic information of the guaranteed person
For details, please refer to the "Announcement on Applying for a Comprehensive Credit Line from the Bank and Providing Guarantees for Subsidiaries" disclosed by the company on cninfo.com (announcement number: 2026-037).
4. Main contents of the guarantee agreement
The main contents of the "Guarantee Contract" signed between the company and Bank of Communications Jingdezhen Branch:
Debtor’s name: Jingdezhen Fuxiang Life Technology Co., Ltd.
Guarantor: Jiangxi Fuxiang Pharmaceutical Co., Ltd.
Creditor: Bank of Communications Co., Ltd. Jingdezhen Branch
Maximum guarantee limit: one hundred and fifty million yuan (lowercase: ¥150,000,000)
Guarantee method: joint liability guarantee
Maximum guarantee: The guarantor provides the maximum guarantee for all main contracts signed by the creditor and the debtor from July 30, 2026 to January 30, 2028. The maximum amount of credit guaranteed by the guarantor is the sum of the following two amounts: 1. The maximum principal balance of the guaranteed principal credit: RMB 150,000,000 Ten thousand yuan, the term "maximum principal balance of the guaranteed principal creditor's rights" as used in this paragraph refers to the maximum principal balance of the principal creditor's rights (including contingent claims) guaranteed by the guarantor under the main contract; 2. Interest (including compound interest, overdue and misappropriation penalty interest), liquidated damages, damages, etc. incurred when the aforementioned principal creditor's rights continue until the guarantor assumes responsibility.
Guarantee scope: principal and interest, compound interest, penalty interest, liquidated damages, damages and costs for realizing the creditor's rights under all main contracts.
Guarantee period: The guarantee period is calculated separately based on the debt performance period of each main debt stipulated in the main contract. The guarantee period under each main debt is from the expiration of the debt performance period to three years after the expiration of the debt performance period of the last due main debt under all main contracts.
5. Cumulative number of external guarantees and number of overdue guarantees
As of the date of this announcement, the company's cumulative total guarantee amount within the validity period is 1.515 billion yuan, all of which are guaranteed by wholly-owned subsidiaries and controlled subsidiaries. The company's cumulative total external guarantees accounted for 69.37% of the company's latest audited net assets. The actual total balance of effective external guarantees was 1.1849 billion yuan (including the newly used guarantee limit this time), accounting for 54.26% of the company's latest audited net assets. The company has no overdue external guarantees, no external guarantees involved in litigation, and no external guarantees that should bear losses due to the judgment of losing the guarantee.
6. Documents for reference
The "Guarantee Contract" signed between the company and Jingdezhen Branch of Bank of Communications Co., Ltd.
Announcement is hereby made.
Board of Directors of Jiangxi Fuxiang Pharmaceutical Co., Ltd.
August 2, 2026